Why Work For Us? Great Pay - opportunity to participate in AAA discretionary annual incentive plan or other incentive plans depending upon position 401k Matching – $1 for $1 company match up to 6% of eligible
Senior Organizational Development Manager AAA Mountain West Group is seeking a strategic and innovative Senior Organizational Development (SOD) Manager to design and deliver transformational leadership experiences. In this high-impact role, you will act as the expert architect for
Authorization & Accreditation Program Lead ICF is seeking an experienced Authorization & Accreditation (A&A) Program Lead to support a Defense Human Resources Activity (DHRA) cybersecurity program. In this role, you will manage and execute Risk Management Framework (RMF) activities across
Security Operations Center (SOC) Manager ICF is seeking an experienced Security Operations Center (SOC) Manager to support a Defense Human Resources Activity (DHRA) cybersecurity program. In this role, you will oversee 24/7 SOC operations, lead a team of analysts performing
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Company Description Join us and make YOUR mark on the World! Lawrence Livermore National Laboratory (LLNL) has turned bold ideas into world-changing impact advancing science and technology to strengthen U.S. security and promote global stability. Our
Director, Clinical Research Scientist Looking for a chance to make a meaningful difference in the oncology space? Taiho Oncology is on a mission: to improve the lives of patients with cancer, their families, and caregivers. Our
Medical Director Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The companys R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic
Senior Director, Clinical Development Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The companys R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS